[ European Foundation For the Study of Diabetes (EFSD) and Novo Nordisk I Research funding on diabetes ]

Event details
Date | 01.02.2019 |
Category | Call for proposal |
The European Foundation for the Study of Diabetes (EFSD) and the healthcare company Novo Nordisk call for applications for the A/S Programme for Diabetes Research in Europe.
Applications from all fields of diabetes research including both basic and clinical research are accepted.
Who can apply:
- Applicants based at non-profit institutions in the EU and Associated Countries.
- The PI and Co-PIs must be normally employed at a non-profit institution and the study must be performed at their place of work.
- Applicants to all EFSD programmes must be paid-up members of EASD.
- Only one EFSD award per PI or Co-PI at a time.
- There can be more than one EFSD award per lab, but for separate projects.
Funding:
- Max. EUR 100’000 for basic research and EUR 400’000 for clinical research.
- The budget must be prepared in EUR and it must mention the exchange rate.
- Please mention all funding requested and obtained from other sources.
- Eligible costs: personnel, 10% OH, equipment, supplies, other project-related costs.
Duration: no upper or lower limit, but must be justified in the application.
Deadline: 1 February 2019 at 18:00 (CET)
Decision: May 2019
For further information, please have a look at the call webpage (incl. evaluation criteria), general instructions, online application portal (incl. the online application form) and past grantees.
Practical information
- General public
- Free